Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details) - Schedule of company???s outstanding warrants and options

v3.22.1
Stockholders’ Equity (Details) - Schedule of company’s outstanding warrants and options
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
1.79 - $20.90 [Member] | Warrants Outstanding [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding | shares 1,043,525
Weighted Average Remaining Contractual Life (in years) 2 years 11 months 23 days
Weighted Average Exercise Price | $ / shares $ 2.57
1.79 - $20.90 [Member] | Warrants Exercisable [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Exercisable | shares 1,043,525
Weighted Average Exercise Price | $ / shares $ 2.57
Intrinsic Value | $
2.64 - $28.50 [Member] | Options Outstanding [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding | shares 118,388
Weighted Average Remaining Contractual Life (in years) 2 years 8 months 8 days
Weighted Average Exercise Price | $ / shares $ 3.25
2.64 - $28.50 [Member] | Options Exercisable [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Exercisable | shares 118,388
Weighted Average Exercise Price | $ / shares $ 3.25
Intrinsic Value | $